| dc.creator |
Kanbay, Mehmet |
|
| dc.creator |
Yilmaz, Mahmut Ilker |
|
| dc.creator |
Covic, Adrian |
|
| dc.creator |
Johnson, Richard J. |
|
| dc.creator |
Ortiz, Alberto |
|
| dc.creator |
Vural, Abdulgaffar |
|
| dc.creator |
Oguz, Yusuf |
|
| dc.creator |
Verim, Samet |
|
| dc.creator |
Gezer, Mustafa |
|
| dc.creator |
Eyileten, Tayfun |
|
| dc.creator |
Saglam, Mutlu |
|
| dc.creator |
Karaman, Murat |
|
| dc.creator |
Unal, Hilmi Umut |
|
| dc.creator |
Siriopol, Dimitrie |
|
| dc.creator |
Afsar, Barış |
|
| dc.date |
2016-07-01T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:29:54Z |
|
| dc.date.available |
2021-12-03T11:29:54Z |
|
| dc.identifier |
67fa7164-61e7-4bae-8873-c9af1be0b5f9 |
|
| dc.identifier |
10.1007/s11255-016-1271-6 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/67fa7164-61e7-4bae-8873-c9af1be0b5f9/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/92327 |
|
| dc.description |
Both elevated serum uric acid and serum asymmetric dimethylarginine (ADMA) are risk factors for cardiovascular disease. We hypothesized that combined elevation of uric acid and ADMA amplifies the risk of all-cause mortality and/or cardiovascular events (CVE) in patients with chronic kidney disease (CKD). |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients |
|
| dc.type |
info:eu-repo/semantics/article |
|